This company has been marked as potentially delisted and may not be actively trading. Idenix Pharmaceuticals (IDIX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IDIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period HS China A Pharmaceuticals (HSCAPI)November 6, 2024 | investing.comPromising Outlook for Syndax Pharmaceuticals: Buy Rating Supported by Clinical Progress and Strategic InitiativesNovember 6, 2024 | markets.businessinsider.comSyndax Pharmaceuticals: Promising Growth Potential Backed by Financial Stability and Lead Product CandidateNovember 6, 2024 | markets.businessinsider.comSyndax Pharmaceuticals (SNDX) Receives a Buy from BarclaysOctober 28, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Amylyx Pharmaceuticals Inc (AMLX) and Intuitive Surgical (ISRG)October 22, 2024 | markets.businessinsider.comIndian drugmaker Alembic Pharma posts Q1 profit rise on strong US salesAugust 9, 2024 | reuters.comSyndax Pharmaceuticals Poised for Growth with Impending Drug Approvals and Strong Commercial ReadinessAugust 3, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Denali Therapeutics (DNLI) and Bio-Rad Laboratories (BIO)August 2, 2024 | markets.businessinsider.comDow Jones Pharmaceuticals & Biotechnology (DJUSPN)May 17, 2024 | investing.comAnalysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Syndax Pharmaceuticals (SNDX) and Tarsus Pharmaceuticals (TARS)May 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Madrigal Pharmaceuticals (MDGL)April 9, 2024 | markets.businessinsider.comiShares U.S. Pharmaceuticals ETFApril 5, 2024 | wsj.comPositive Outlook for Citius Pharmaceuticals with Lymphir’s FDA Resubmission and Market PotentialMarch 20, 2024 | markets.businessinsider.comImprimis Pharmaceuticals earnings: here's what Wall Street expectsMarch 18, 2024 | markets.businessinsider.comNYSE Arca Pharmaceutical IndexJanuary 22, 2024 | wsj.comRigel Pharma Collaborates With CONNECT To Conduct Phase 2 Trial Of Olutasidenib In GliomaJanuary 4, 2024 | markets.businessinsider.comWhy Biodexa Pharmaceuticals Stock (BDRX) Is SkyrocketingNovember 27, 2023 | benzinga.comHold Rating on Inovio Pharmaceuticals: Potential Expedited Approval and Commercialization of INO-3107 for Recurrent Respiratory PapillomatosisOctober 11, 2023 | markets.businessinsider.comNexus Pharmaceuticals Receives FDA Approval for Fluorescein Injection, USPSeptember 26, 2023 | benzinga.comWhy Intercept Pharmaceuticals Stock Is Skyrocketing TodaySeptember 26, 2023 | msn.comKOSDAQ Pharmaceuticals Technical AnalysisSeptember 11, 2023 | investing.comChina drugmakers axe IPO plans as they face scrutiny in anti-graft driveAugust 11, 2023 | msn.comInDex Pharmaceuticals Holding ABJuly 20, 2023 | morningstar.comMLegal & General Global Health & Pharmaceuticals Index Trust R Class Accumulation (0P00000C79)July 16, 2023 | investing.comEndo International Says Health Canada Approves XCOPRI To Treat EpilepsyJune 29, 2023 | markets.businessinsider.comBoard Member at Impel Pharmaceuticals Acquires Company Stock Options Worth 13,222 SharesJune 21, 2023 | benzinga.comFirst-of-its-kind erectile dysfunction gel gets FDA’s OK for over-the-counter marketing, company saysJune 12, 2023 | cnn.comDrugmaker Mallinckrodt may file for bankruptcy again -WSJJune 3, 2023 | reuters.comS&P 500 Pharmaceuticals Biotechnology & Life Sciences Industry Group IndexMay 28, 2023 | wsj.comMerck Adds HCV Candidates with Idenix BuyMay 17, 2023 | thestreet.comInDex Pharmaceuticals Holding AB (INDEX)April 7, 2023 | investing.comTOPIX Pharmaceutical Technical AnalysisApril 6, 2023 | investing.comHere's what Wall Street expects from Imprimis Pharmaceuticals's earningsMarch 22, 2023 | markets.businessinsider.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call TranscriptMarch 6, 2023 | insidermonkey.comShareholder Alert: Ademi LLP investigates whether Infinity Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with MEI PharmaFebruary 23, 2023 | benzinga.comDow Jones U.S. Pharmaceuticals IndexFebruary 19, 2023 | wsj.comInovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms marketJanuary 25, 2023 | marketwatch.comH.C. Wainwright Reaffirms Their Buy Rating on Inozyme Pharma (INZY)January 10, 2023 | markets.businessinsider.comInovio Pharmaceuticals Inc. stock outperforms market on strong trading dayDecember 14, 2022 | marketwatch.comU.S. FDA approves Rigel Pharma's leukemia treatmentDecember 1, 2022 | reuters.comCitigroup Maintains Sell on Ionis Pharmaceuticals, Raises Price Target to $31November 11, 2022 | benzinga.comAmneal Pharma Gets FDA Approval For Leuprolide Acetate InjectionNovember 2, 2022 | markets.businessinsider.comRigel to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 6, 2022 | finance.yahoo.comBiotech Calendar: Key Dates and EventsAugust 21, 2022 | thestreet.comIntercept Pharmaceuticals Announces Repurchase of Convertible NotesAugust 19, 2022 | finance.yahoo.comCOVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatmentAugust 18, 2022 | finance.yahoo.comMarketmind: Investors eye Aussie jobs data, digest Fed minutesAugust 17, 2022 | msn.comIntercept Settles Ocaliva Litigation With Reddy's LabAugust 17, 2022 | finance.yahoo.comReturns On Capital At IDEX (NYSE:IEX) Have StalledAugust 10, 2022 | finance.yahoo.comOtsuka Pharmaceutical and Lundbeck to Present Phase 3 Data for Brexpiprazole in Patients with Alzheimer's Dementia at AAIC 2022August 2, 2022 | benzinga.com Get Idenix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDIX Media Mentions By Week IDIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDIX News Sentiment▼0.000.73▲Average News Sentiment IDIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDIX Articles This Week▼02▲IDIX Articles Average Week Get the Latest News and Ratings for IDIX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Idenix Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMGN News GILD News VRTX News REGN News ALNY News BIIB News UTHR News INCY News NBIX News BMRN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDIX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idenix Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Idenix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
